For millions of people living with swollen legs, venous ulcers, lymphedema, and chronic venous insufficiency, compression therapy is a lifelong treatment rather than a temporary solution.
Traditional compression bandages often lose pressure, require trained clinicians for application, and need frequent replacement. Adjustable compression wraps have emerged as a practical alternative by allowing patients to apply consistent compression on their own while improving comfort and treatment adherence.
Why Adjustable Compression Wraps Are Seeing Higher Demand
The growing demand is directly linked to the increasing number of patients with chronic diseases that affect blood circulation and lymphatic drainage.
According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 6.7 million adults in the United States live with chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure injuries.
The National Institutes of Health (NIH) estimates that 3 million to 10 million Americans suffer from lymphedema, while worldwide cases exceed 250 million people.
The World Health Organization (WHO) reports that by 2030, 1 in every 6 people globally will be aged 60 years or older, significantly increasing the population requiring long-term compression therapy.
These patients require compression treatment for months or even years, creating consistent demand for reusable compression wraps.
Consumer Insights: Patients Want Comfort More Than Anything
Consumer preference has shifted significantly over the past decade.
Patients no longer choose products based only on medical effectiveness. Ease of use, comfort, and independence have become equally important purchasing factors.
Clinical studies published by the National Library of Medicine found that patient adherence to traditional multilayer compression bandages ranges between 40% and 60%, mainly because they are difficult to apply and uncomfortable during daily activities.
Studies evaluating adjustable compression wraps reported treatment compliance exceeding 80%, largely because patients could adjust pressure themselves throughout the day.
Healthcare providers have also observed fewer clinic visits for bandage replacement among patients using adjustable wraps.
Consumer Statistics
| Consumer Insight | Real Data |
|---|---|
| Americans living with lymphedema | 3–10 million |
| Global lymphedema patients | 250+ million |
| Adults with chronic wounds (U.S.) | 6.7 million |
| Compliance with traditional compression | 40–60% |
| Compliance with adjustable wraps | Above 80% |
| Population aged 60+ by 2030 (WHO) | 1.4 billion |
Manufacturing: Precision Matters More Than Volume
Manufacturing adjustable compression wraps involves advanced medical textile engineering rather than conventional garment production.
Every product must deliver a specific therapeutic pressure, maintain elasticity after repeated use, and withstand daily adjustments without material fatigue.
The manufacturing process generally includes:
Step 1: Medical Textile Production
Manufacturers use high-strength nylon, polyester, polyurethane elastomers, and microfiber fabrics.
These materials provide flexibility while maintaining controlled compression levels.
Step 2: Pressure Calibration
Unlike ordinary elastic fabric, every wrap is engineered to deliver medical compression levels such as:
- 20–30 mmHg
- 30–40 mmHg
- 40–50 mmHg
These pressure ranges are validated through laboratory testing before commercial production.
Step 3: Hook-and-Loop Integration
Manufacturers attach medical-grade fastening systems that allow patients to tighten or loosen the wrap without affecting therapeutic pressure.
Premium products undergo thousands of fastening cycle tests before approval.
Step 4: Quality Testing
Manufacturers perform:
- Tensile strength testing
- Stretch recovery testing
- Wash durability testing
- Compression consistency testing
- Biocompatibility testing
Most global manufacturers operate under ISO 13485 medical device quality standards.
Looking for data that supports your next business decision? Get a FREE sample tailored to your strategic priorities: https://www.towardshealthcare.com/download-sample/7013
Manufacturing Landscape by Region
Germany: Global Leader in Compression Textiles
Germany has built one of the world’s strongest medical textile industries.
Companies such as medi GmbH, Juzo, Bauerfeind, and Lohmann & Rauscher manufacture premium compression products exported to more than 90–100 countries.
Germany’s medical technology industry generated approximately €41.4 billion (USD 45 billion) in revenue in 2024, with nearly 68% of production exported worldwide. More than 1,500 medical technology companies operate across the country, making Germany Europe’s largest medical device manufacturing hub.
The country’s reputation comes from decades of expertise in medical knitting technologies, continuous R&D investment, and strict MDR (Medical Device Regulation) compliance.
United States: Innovation and Clinical Research
The U.S. focuses more on innovation than manufacturing volume.
Companies invest heavily in product development, reimbursement programs, clinician education, and digital fitting technologies.
According to the Advanced Medical Technology Association (AdvaMed), the U.S. medical technology industry generates more than USD 215 billion in annual domestic sales and supports over 2 million jobs. The country accounts for nearly 40% of the global medical device market, making it the largest healthcare technology market worldwide.
Its large wound care market, favorable Medicare reimbursement policies, and aging population continue driving demand for adjustable compression therapy.
China: Large-Scale Manufacturing Hub
China has become one of the largest producers of medical textiles globally.
Its competitive labor costs, integrated textile supply chains, and expanding medical device manufacturing capacity make it a preferred production base for international brands.
China’s medical device market exceeded CNY 1.3 trillion (approximately USD 180 billion) in 2024. The country has more than 35,000 registered medical device manufacturers, with Jiangsu, Guangdong, Zhejiang, and Shandong serving as major production hubs for medical textiles and rehabilitation products.
Many global companies also source compression garments and orthopedic supports through Chinese OEM and contract manufacturers.
India: Emerging Manufacturing Destination
India’s medical textile industry continues expanding under government initiatives supporting domestic manufacturing.
Indian manufacturers increasingly supply compression garments, orthopedic supports, and rehabilitation products to hospitals in Asia, Europe, the Middle East, and Africa.
According to the Ministry of Textiles, India’s technical textiles market reached approximately USD 26 billion in 2024, with Meditech accounting for nearly USD 2.3–2.5 billion. India exports medical textiles and related products to more than 100 countries, supported by the Production Linked Incentive (PLI) Scheme and the National Technical Textiles Mission.
Lower production costs and improving regulatory compliance continue strengthening India’s position as an emerging manufacturing destination.
Top Companies and Their Financial Performance
Essity AB (Sweden)
Essity owns the globally recognized JOBST compression therapy brand.
2025 Net Sales: SEK 146 billion (approximately USD 13.8 billion).
The company’s Health & Medical business includes compression therapy, wound care, and orthopedic products sold in more than 150 countries.
Cardinal Health (United States)
Cardinal Health is one of the world’s largest healthcare distributors.
FY2025 Revenue: Approximately USD 226.8 billion.
Its Medical Products segment distributes compression therapy products to thousands of hospitals and healthcare facilities worldwide.
Solventum (United States)
Formerly 3M Health Care.
2025 Revenue: Approximately USD 8.3 billion.
Advanced wound care remains one of its major business divisions alongside medical technologies.
SIGVARIS Group (Switzerland)
SIGVARIS specializes entirely in compression therapy.
The company sells products across 70+ countries and continues investing in digital patient measurement technologies and customized compression solutions.
medi GmbH & Co. KG (Germany)
medi exports compression therapy products to more than 90 countries.
The company invests heavily in clinical research and develops products for lymphedema, venous disease, and orthopedic rehabilitation.
Company Strategies Driving Sales
Leading manufacturers are no longer competing only on product quality.
They are building complete treatment ecosystems.
Their strategies include:
- Direct partnerships with wound care clinics
- Home healthcare training programs
- Digital pressure measurement systems
- Online patient education
- Insurance reimbursement support
- Expansion into emerging Asian markets
- Investment in reusable and sustainable products
These strategies improve patient retention while increasing long-term product sales.
Sales Performance and Market Demand
Hospitals remain the largest buyers of adjustable compression wraps.
However, home healthcare is becoming the fastest-growing sales channel as healthcare systems aim to reduce hospital admissions and improve patient self-management.
According to Grand View Research, the global compression therapy market was valued at approximately USD 4.3 billion in 2024, while the advanced wound care market exceeded USD 11 billion. Adjustable compression wraps are witnessing increasing adoption due to their reusability and improved patient compliance.
The United States remains the largest revenue-generating region, accounting for approximately 38–40% of global compression therapy sales, driven by high healthcare spending, reimbursement coverage, and a large chronic wound patient population.
Europe represents the second-largest regional market with nearly 30% market share, supported by aging demographics, well-established vascular disease treatment programs, and widespread use of compression therapy across Germany, France, Italy, and the United Kingdom.
Asia-Pacific is the fastest-growing region, supported by rising healthcare expenditure. According to the World Bank, healthcare spending in East Asia and the Pacific exceeded USD 2 trillion annually, while China and India continue investing heavily in hospital infrastructure and medical device manufacturing.
Demand is also supported by the growing prevalence of diabetes. According to the International Diabetes Federation (IDF), approximately 589 million adults are expected to be living with diabetes by 2035, significantly increasing the number of patients requiring compression therapy for diabetic foot ulcers, venous leg ulcers, and chronic edema.
Healthcare providers are also shifting toward reusable compression systems because they reduce clinician time, improve patient adherence, and lower long-term treatment costs compared to conventional multilayer compression bandages.
Government Data Supporting Future Demand
Government health agencies continue reporting rising numbers of chronic diseases requiring compression therapy.
| Government Organization | Real Data |
|---|---|
| WHO | 1 in 6 people globally will be aged 60+ by 2030 |
| CDC | 6.7 million U.S. adults live with chronic wounds |
| NIH | 3–10 million Americans have lymphedema |
| International Diabetes Federation | 589 million adults expected to have diabetes by 2035 |
| U.S. Census Bureau | Adults aged 65+ projected to reach nearly 82 million by 2050 |
These demographic trends indicate a sustained increase in demand for compression therapy products, particularly reusable adjustable wraps that support long-term home-based care.
Access our exclusive, data-rich dashboard dedicated to the medical devices sector – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Checkout the Market Report Now at:
About Us
Healthcare WebWire is a part of Towards Healthcare Research and Consulting delivers strategic insights across the medical devices market, including diagnostic devices, surgical equipment, imaging systems, wearable technologies, cardiovascular devices, and orthopedic implants. We help healthcare innovators track market trends, optimize product strategies, and drive growth through data-driven intelligence and industry expertise.
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at [email protected]
Powering Healthcare Leaders with Real-Time Insights: https://www.towardshealthcare.com/healthcare-intelligence-platform
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium